Respiratory

Ensifentrine, an innovative dual bronchodilator and anti-inflammatory medication, has shown promising results in reducing healthcare usage among patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Critical insights into outpatient antibiotic use and treatment failure rates among U.S. children diagnosed with pneumonia, underscoring significant gaps in care, have been revealed in a new study.

A significant increase in walking pneumonia cases among children, largely attributed to Mycoplasma pneumoniae infections, is drawing attention from U.S. healthcare professionals.

A reported rise in respiratory infections has been issued by the U.S. CDC, particularly Mycoplasma pneumonia and RSV.

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.

A nationwide study presented at the CHEST Annual Meeting 2024 revealed rising trends in metabolically healthy obesity (MHO) among elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease

A strong link has been identified between the cumulative impact of neighborhood-level environmental and social factors, known as the “neighborhood exposome,” and the prevalence of asthma and COPD in U.S. adults

A new study has shown that the BACES score, a clinical tool used to predict mortality in non-tuberculous mycobacteria (NTM) lung disease, can also help predict treatment outcomes in patients with Mycobacterium avium complex lung disease (MAC-LD)